/

Investors / France / Kurma Partners

Kurma Partners

Venture capital · Paris, France · Europe

kurmapartners.com

Kurma Partners is a European investment firm focused on healthcare and biotechnology. It works with academic research teams to create companies and also finances early-stage companies that already exist, providing capital and inviting other investors to join.

Invests inHealthcare & Biotech

In its own wordshealthcarebiotechnologymedicinesmedical devicescompany creationesg

Your fit with Kurma Partners

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
56portfolio companies
12funding rounds on record7 led
5rounds, last 12 months
$20M to $100Mtypical round it comes in at
Seedmost frequent entry

Kurma Partners lists 56 checked portfolio companies on its own site and is named in 12 funding rounds, 7 of them as lead. Its most frequent entry is Seed, 40% of the companies with a known first round. Its largest themes are Healthcare & Biotech (94%), AI & Machine Learning (4%) and Fintech (2%). 40% of its companies are based in France. It invests most often alongside Agoranov, Angelini Ventures and Ysios Capital.

Counts come from funding rounds that name Kurma Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not Kurma Partners' whole history. Rounds on record name 11 companies; its own site lists 56. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed0%
Seed40%
Series A30%
Series B30%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2311
'2400
'2574
'2642

Investor profile

percentile among all firms
Portfolio size: 56 companiesRecent activity: 5 rounds in 12 monthsEarly stage: 40% of entries at pre-seed or seedEvidence: 14% of companies confirmed by a roundSector focus: 94% in its largest sectorReach: 10 countriesPortfolio size86th pctRecent activity86th pctEarly stage66th pctEvidence85th pctSector focus96th pctReach95th pct
This firmMedian of all firms
Show as a table
Kurma Partners compared with all firms
MeasurePercentile of all firmsValue
Portfolio size86th56 companies
Recent activity86th5 rounds in 12 months
Early stage66th40% of entries at pre-seed or seed
Evidence85th14% of companies confirmed by a round
Sector focus96th94% in its largest sector
Reach95th10 countries

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
Agoranov8
Angelini Ventures7
Ysios Capital6
Sunstone Life Science Ventures5
Pureos Bioventures4
Seroba Life Sciences4
V-Bio Ventures4
BioGeneration Ventures3

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers5598%
  • No longer answers00%
  • Points to another company12%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech94%15%
AI & Machine Learning4%18%
Fintech2%12%

Compare Kurma Partners head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Recent portfolio activity

when companies last raised with Kurma Partners
DateCompanyStage
6 Oct 2026RougeTxrougetx.comSeries A Led
29 Apr 2026Tacalyxtacalyx.comSeed
23 Mar 2026Laigo Biolaigobio.comSeed Led
8 Jan 2026Alveus Therapeuticsalveustx.comSeries A
4 Dec 2025Laigo Biolaigobio.comSeed Led
16 Oct 2025Adcytherix SASadcytherix.comSeries A
25 Sept 2025us.hellosunrise.comus.hellosunrise.comRound
10 Jul 2025Nuclidiumnuclidium.comSeries B Led

Round details for Kurma Partners

Amounts, full round histories and every co-investor in Kurma Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

56 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Adcytherix SASadcytherix.com · FranceAdcytherix is building an antibody-drug conjugate powerhouse to advance patient-need-driven therapies
Healthcare & Biotech
Oct 2025Series APage + round
Alveus Therapeuticsalveuspharma.co.in · IndiaAlveus Pharmaceuticals is a pharmaceutical development company that provides services for development and manufacturing of drugs.
Healthcare & Biotech
Portfolio page
Alveus Therapeuticsalveustx.com · United StatesAlveus Therapeutics develops treatments for obesity and weight loss maintenance
Healthcare & Biotech
Jan 2026Series AFunding round
AM Pharmaam-pharma.com
Portfolio page
Argobio Studioargobiostudio.com · FranceArgobio Studio builds the next generation of European biotech champions by turning scientific discoveries into investable companies
Healthcare & Biotech
Portfolio page
Asceneuronasceneuron.com · SwitzerlandAsceneuron discovers and develops therapeutics for neurodegenerative disorders
Healthcare & Biotech
Portfolio page
Avidicureavidicure.com · NetherlandsAvidicure develops antibodies for patients with oncology and autoimmune diseases
Healthcare & Biotech
Portfolio page
Axithraaxithra.comAxithra develops technology for rapid therapeutic drug monitoring at the point of need
Healthcare & Biotech
Portfolio page
BioSerinitybioserenity.com
Portfolio page
BliNKblinkbiomedical.com · FranceThe company identifies and isolates antibodies directly from human B cells for therapeutic purposes.
Healthcare & Biotech
Portfolio page
brinktx.combrinktx.com · United StatesBrink Therapeutics is engineering a platform for precise, large-scale genomic integration using programmable integrases
Healthcare & Biotech
Apr 2025SeedFunding round
Kirobyond.bioKiro provides a platform for users to access and understand their medical test results
Healthcare & Biotech
Portfolio page
Cardiologscardiologs.comCardiologs provides ECG analysis software solutions utilizing clinically validated AI to help reduce the burden of ECG analysis for clinicians and service providers.
Healthcare & Biotech
Portfolio page
Charles Cocharles.co · FranceThe company provides online medical consultations and personalized diagnoses
Healthcare & Biotech
Portfolio page
Coave Therapeuticscoavetx.com · FranceCoave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS diseases.
Healthcare & Biotech
Portfolio page
Corteria Pharmaceuticalscorteriapharma.comCorteria Pharmaceuticals is a privately held company developing first-in-class drugs for indications of high unmet medical need, such as obesity, heart failure subpopulations and autosomal dominant polycystic kidney disease
Healthcare & Biotech
Portfolio page
Deepulldeepull.comDeepull is developing technology to detect sepsis-causing pathogens and antibiotic resistance markers directly from blood
Healthcare & Biotech
Portfolio page
DNA Scriptdnascript.com · FranceDna Script develops and provides DNA synthesis technology and products for laboratories and companies.
Healthcare & Biotech
Portfolio page
Elkedoniaelkedonia.comElkedonia is developing a neuroplastogen for antidepressant therapy
Healthcare & Biotech
Portfolio page
Germitecgermitec.comGermitec develops and markets UV-C disinfection devices for ultrasound probes and other medical equipment
Healthcare & Biotech
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of Kurma Partners, as last read
kurmapartners.com as VCinfo last read it
Site
kurmapartners.com
Last read
5 Nov 2026
Watching since
5 Nov 2026
Rounds since
5 Oct 2023
Companies checked
56

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Kurma Partners' profile as data

Pull Kurma Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/kurmapartners.com

# also
GET /v1/firms/kurmapartners.com/portfolio
GET /v1/firms/kurmapartners.com/coinvestors
GET /v1/firms/kurmapartners.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing